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Background: Culturing primary cortical neurons is an essential neuroscience technique. However, most cultures are
derived from rodent brains and standard protocols for human brain cultures are sparse. Herein, we describe
preparation, maintenance and major characteristics of a primary human mixed brain culture, including neurons,
obtained from legally aborted fetal brain tissue. This approach employs standard materials and techniques used in
the preparation of rodent neuron cultures, with critical modifications.
Results: This culture has distinct differences from rodent cultures. Specifically, a significant numbers of cells in the
human culture are derived from progenitor cells, and the yield and survival of the cells grossly depend on the
presence of bFGF. In the presence of bFGF, this culture can be maintained for an extended period. Abundant
productions of amyloid-β, tau and proteins make this a powerful model for Alzheimer’s research. The culture also
produces glia and different sub-types of neurons.
Conclusion: We provide a well-characterized methodology for human mixed brain cultures useful to test therapeutic
agents under various conditions, and to carry forward mechanistic and translational studies for several brain disorders.
Keywords: Alzheimer, Amyloid, Cholinergic, Dopaminergic, Development, Glutamatergic, Human brain culture, CNS,
Confocal microscopyBackground
Primary brain and neuron cultures are used for neuro-
biological, neurodevelopmental, pharmacological and
toxicological studies in various neuropsychiatric disor-
ders. To date, the majority of the neuron cultures are
prepared from embryonic rodent brains [1,2] and very
few from adult rodent brain [3,4]. Rodents are preferred
for preparing primary cultures because of availability,
lower expense and less stringent regulations. How-
ever, rodents normally do not experience human-like
neurodegenerative disorders such as Alzheimer’s disease
(AD) or Parkinson’s disease (PD). Additionally, mole-
cules involved in important pathological events (such
as amyloid-β or Aβ and α-synuclein) in human* Correspondence: dlahiri@iupui.edu
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unless otherwise stated.neurodegenerative disorders are structurally different in
rodents. Many continuous cell lines, such as human
neuroblastoma or rat pheochromocytoma (PC12), are
used as surrogate models for mature neurons by stimulat-
ing neuronal-type differentiation of the culture. However,
these cancer cells may behave differently than CNS neu-
rons. Recently, major emphasis has been given to differen-
tiate human neurons from induced pluripotent stem cells
(iPSC). However, this method could be expensive, time
consuming and overall, the iPSCs are artificially trans-
duced with several transcription factors. In the past, efforts
have been made to prepare neuron cultures from the fetus
of nonhuman primates [5,6], but the stringent regulation
and scarcity of nonhuman primate colonies are major ob-
stacles to performing such cultures on a regular basis. We
have recently developed and characterized a primary
neuron culture derived from the parenchyma of legally
aborted human fetal brains. A small number of research
groups have previously reported the use of primary human
fetal neuron cultures in their studies [7-15]. While fetal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ray et al. Molecular Brain 2014, 7:63 Page 2 of 15
http://www.molecularbrain.com/content/7/1/63cultures have been used to examine the effects of estrogen
[12], and laminin [16], a detailed protocol for preparing,
maintaining and characterizing such cultures is lacking.
Neuroprogenitor cells from adult donors’ brains are also
available from commercial sources, or have been cultured
[15,17,18], but are difficult to grow and also lack detailed
characterization. It is possible to generate astrocytic and
oligodendrocytic [15] cultures from fetal tissue as well.
However, there remains a dearth of publications that out-
line the culture of a mixed neuronal culture derived from
human tissue. One such article [13] was able to demon-
strate neuronal and glial positive staining and the forma-
tion of synaptic boutons. Notably, we are able to show
quantitation of the immunostaining and measure physio-
logical activity of our neurons using flow cytometry and
calcium imaging respectively. Moreover, the applicability
of our culture to studying neurodegenerative disorders has
been shown by our ability to demonstrate the presence of
several neuronal and synaptic markers and of significant
levels of Alzheimer’s Aβ peptides, and the transfectabil-
ity of small RNA species, such as siRNAs. Therefore,
we are able to outline a protocol for a culture that dis-
plays: a) both neuronal and glial characteristics; b)
physiological activity; c) the potential for extensive utility
across neuroscience. We have successfully employed the
primary culture system described in this protocol in our
research workflow [19].
Results and discussion
Major differences between primary human and rodent
embryonic neuron culture
The human brain is approximately sixty times larger
than the mouse brain. The majority of the neurons ob-
tained from fetuses (90–110 days gestational age) are
immature. Development of the human cerebral cortex
begins at the end of the first trimester and continues
through the second trimester [20]. Since this protocol
utilizes brain tissue from fetuses at a gestational age
slightly beyond 90 days (i.e. first trimester), the majority
of the neurons are immature, and a good proportion of
isolated cells are neuroblast and/or neural progenitor
(NPCs) in nature. At the initial phase of the cultures,
the cells co-express markers of both neuronal and glial
origin, consistent with the immature nature of cells in
culture. After a longer period of culture, both mature
neurons and glia are present. This is an important fea-
ture of this culture and contrasts with primary embry-
onic rodent cultures, where the culture is generally
prepared from embryonic day 16–18 (E16-E18) brain;
equivalent to the third trimester of human pregnancy.
Therefore, these rodent brains contain many more
post-mitotic neurons than the human fetal neuron cul-
tures. We have characterized the human culture and
observed mature neurons and glia in the culture fromday in vitro (DIV) 20 onwards. Around this point of
time, neurons and glia can be visualized separately by
immunofluorescence staining using specific neuronal
and glial markers.
Generation of viable cells that stain for neuronal and glial
markers
We outline a procedure (Figure 1) to show the plating of
primary human brain culture. We confirmed that these
cells were viable, in vitro, until at least DIV 40 (Figure 2)
and that they continue to show cells that have neuronal
morphology with a network of processes. In order to
confirm the identity of these cells, we first performed
immunocytochemistry using antibodies to neuronal and
glial markers (Figure 3). We found that the culture con-
tains both the aforementioned cell types. This is import-
ant, as it may provide an appropriate in vitro model for
studying neurodegeneration and neurodevelopment.
Effects of growth factors on neuronal viability and
differentiation
In order to prepare and maintain healthy neuronal cul-
tures, we have tested several growth factors by observing
their effects on neuronal differentiation. Basic fibroblast
growth factor (bFGF) produces the best response in
terms of long-term culture growth and differentiation.
Previous studies have shown that FGF treatment pro-
motes cortical neurogenesis by inducing proliferation of
NPCs, resulting in an increased number and density of
glutamatergic and GABAergic neurons [21]. Concomi-
tantly, the presence of bFGF also increases the glial
population by acting as a mitogen for glial precursor
cells [22]. bFGF also induces neuronal differentiation
and preserves the stem-cell population in the NPCs
[23,24]. Indeed, nestin-positive cells (a well-known marker
for neural stem cells [25]) are frequently observed in
the culture described here (Figure 4, Additional file 1:
Figure S1). We have observed diminished cellular via-
bility and differentiation when BDNF and/or GDNF
were added separately in the beginning (DIV 4) of the
culture in the absence of bFGF. However, no signifi-
cant alteration in culture character was noticed when
BDNF (25 ng/mL) and/or GDNF (25 ng/mL) were separ-
ately added to the culture at a later time point (DIV 8),
when the culture received bFGF from DIV 0–8 (Figure 4).
We have also assessed the effects of other growth factors
including nerve growth factor (NGF), glial cell-derived
neurotrophic factor (GDNF) and other differentiation pro-
moters, such as retinoic acid (RA) and forskolin, and no-
ticed similar results (data not shown).
Characterization of the mixed brain culture
In order to elucidate the molecular identity of our mixed
culture, we used western blotting (Figures 5 and 6),
Figure 1 Schematic diagram summarizing the major steps involved in the procedure to prepare human neuron culture. Also shown are
6-well, 12-well and 24-well formats that can be used for different biochemical and physiological studies pertaining to neuroscience. The inset
shows a schematic of miRNA transfection into the culture.
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and fluorescence activated cell sorter (FACS) (Figure 9).
The human primary neuronal culture described here can
serve as a relevant, rational and suitable tissue culture
model for research on neurodegenerative disorders like
AD, PD and other brain disorders. This culture contains
measurable levels of synaptic (PSD-95, SNAP-25); glial
(GFAP) and neuronal specific (NSE) proteins as evalu-
ated by western blotting (Figure 5). Deposition of Aβ
peptides and hyperphosphorylation of microtubule asso-
ciated protein tau is the major hallmarks of AD. We
have observed that this culture system produces signifi-
cant amounts of Aβ (1–40) and Aβ (1–42), as assessed by asensitive, human-specific ELISA. We have also measured
AB at other time points [19]. At DIV 18, the amounts of
Aβ (1–40) and Aβ (1–42) were measured to be 806.76 ±
212.02 pg/mL and 352.43 ± 95.95 pg/mL, respectively. We
have also measured total and phospho-tau levels in the
cell lysate samples by Western immunoblotting using spe-
cific antibodies. Total and phospho-tau levels were de-
tected throughout the time points of the culture with
highest peaks from DIV 28 onwards (Ray & Lahiri Unpub-
lished data). The presence of tyrosine hydroxylase-positive
neurons (Figure 6b) also makes this neuron culture appro-
priate for research related to PD. Serotonergic neurons
and GABAergic neurons are also detectable, (Figure 6a
Figure 2 Phase contrast pictures (20 X magnification) showing the gross morphology of the cells at different time points of the
culture. Rounded cell bodies can be seen soon after plating the cells. Discrete cell clumps are visible at the early time points of the culture.
Significant proportions of cells at this time point represent NPCs, which later on give rise to neurons and astrocytes. Abundant numbers of cells
are present even at DIV40 of the culture. The insets are representative portions from the same image that have been enlarged.
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iety of studies requiring these particular neuronal sub-
types. Furthermore, the neurons present in the culture are
suitable for electrophysiological study because of the ex-
pression of voltage-gated calcium channels (VGCC) as
measured by Fura-2 AM experiments (Figure 8). The cells
respond to depolarization by 70 mM KCl by allowing an
influx of calcium, suggesting the presence of active
VGCCs. We observed KCl-evoked Calcium influx at all
three time points studied – DIV 4, DIV 16 and DIV 28
(Figure 8). The experiments show that these cells have a
resting intracellular calcium level of 40 nM (data not
shown). The slightly lower than expected intracellular cal-
cium may be a consequence of the mixed cell culture that
contains both mature and immature neurons.
Interestingly, the numbers of nestin and pan-neuronal co-
labeled cells are higher in number at the initial phase of the
culture (Figure 9) and gradually increase neuronal positive
markers, suggesting an in vitro maturation process. Neverthe-
less, we observe presence of some nestin (Figures 7 and 9)
positive cells during all time points of the maintained culture
possibly explaining why we can maintain the culture for an ex-
tended period of time. Although we observe coexpression of
neuronal and glial markers (Figure 9) during the early DIV, we
see an increase in neuronal staining at the later stages of
in vitro maturation. However, we do continue to see a small
cluster of cells that continue to coexpress the two markers.
Testing transfectability of nucleic acids in primary human
brain culture
With appropriate maintenance, this neuronal culture
can be kept viable for more than 40 DIV, thus making it
a powerful tool for aging and/or toxicological research.
In our hands, these cells are readily transfectable with
small RNA constructs [27]. For example, we were able
to knockdown ~50% of the amyloid precursor protein(APP) levels by transfecting this culture with APP siRNA
at DIV 18 of the culture (Figure 10).
Experimental design
This protocol describes an effective way to culture a viable
mixed population of cells (both neurons and glia), which
can survive in vitro for a prolonged period of time. Some
important methodological alterations from primary rodent
neuronal culture preparations were introduced to effi-
ciently prepare such cultures for better neuronal yield and
viability. An outline and salient features of the human pri-
mary neuronal culture preparation and progression is
shown in Figure 1. Initially, the extracellular matrices and
supporting stroma of human aborted fetal brains are sig-
nificantly more abundant than in rodent brains, requiring
an effective proteolytic digestion step. Meticulous dissec-
tion/processing of fetal brains to remove blood stained tis-
sue is important to minimize the chance of contamination
of the culture. It may be necessary to apply a broad-
spectrum cocktail of antibiotics due to the inherent lack of
sterility in the process of obtaining abortus material. The
processed cell suspension (step 5 in Figure 1) can also be
used for culturing neurospheres with appropriate media
and growth factors [28]. Finally, this protocol can only be
used after proper ‘Institutional Review Board’ (IRB) ap-
proval for the use of aborted human fetal tissue.
Conclusion
We have successfully prepared human primary neuron
cultures following our protocol and observed consistency
in terms of cellular morphology, growth pattern, and neur-
onal maturation across cultures. The cells have demon-
strated neurite sprouting from DIV 6–8. Cells at earlier
time points aggregated in condensed clumps situated dis-
cretely across the plate. Major proportions of the cells
were neuroprogenitors that gave rise to neurons and glia
Figure 3 ICC study of the culture using neuronal and glial-specific marker shows the presence of both the phenotypes in the culture.
Interestingly, cells at the initial period of the culture are labeled with both neuronal and glial markers indicating newly generated or immature
cells. However, the cells become mature at the later time points (DIV 20–24), when neurons and glia are stained separately by pan-neuronal and
GFAP antibodies, respectively.
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flux in response to depolarization that are consistent with
the presence of active VGCC. We observed that neurons
in the culture matured no later than DIV 24. In the
presence of bFGF, the culture survived for at least 40 days.
To prepare such cultures, we used brains from aborted fe-
tuses of gestational age between 85–110 days (Table 1).
We also confirmed the transfectability of the cell culture
using siRNA.Materials and methods
Human fetal brain tissue
Human fetal brain tissue samples were obtained from
aborted fetus of gestational age between 90–110 days.
Aborted fetal brain tissues can be obtained from local
abortion clinics or national distribution labs. In this
study, we procured human fetal brain tissue samples
from electively aborted legal aborted fetuses from the
Laboratory of Developmental Biology, Seattle, WA
Figure 4 Effects of growth factors in neuronal viability and differentiation. To determine the requirement and effectiveness of different
growth factors in neuronal survival and differentiation, we plated neurons with bFGF at DIV0 and changed complete media at DIV4. In the first
experiment, at DIV4, different growth factors (bFGF, BDNF and GDNF) were added separately to the culture. A half-media change with the
addition of respective growth factors was performed at DIV8, and the cells were fixed at DIV12. In the second experiment, cells received bFGF
from DIV 0–8, thereafter media was aspirated off and fresh media containing bFGF, BDNF and GDNF were added separately. Cells were fixed at
DIV 12. Fixed cells from both the experiments were permeabilized and then incubated with Pan-neuronal and GFAP or Pan-Neuronal and Nestin
primary antibodies. Cells were incubated with appropriate fluorophore-conjugated secondary antibodies, washed off excess unbound antibodies,
and immunofluorescent images were captured as stated in the text. Nuclei were stained by Hoechst dye. The figures were pseudocolorized using
Adobe Photoshop CS4, where Pan-Neuronal-positive cells were colorized green, GFAP and Nestin-positive cells red and Hoechst were shown in
blue. The figures depicted that cellular viability and differentiation were grossly decreased in the cultures that were supplemented by bFGF from
DIV0-4, but received BDNF and GDNF from DIV4–12. However, cellular viability and differentiation were not affected in the group that received
bFGF from DIV0–12. Contrarily, we have not noticed any alteration in cellular viability and differentiation in the cultures that were supplemented
by bFGF from DIV0-8 and then supplemented by either bFGF, BDNF or GDNF from DIV8-12. These results indicate that supplementation by bFGF
at the initial phase of the culture is essential for proper development and differentiation. Arrows indicate cell bodies that stain for
both antibodies.
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sue is dependent on lab hours, donor visitation and the
age of the samples desired. Coincidentally, all our HFN
cultures were from male samples.
Handling and research utilizing human aborted fetal
tissue requires prior approval from Indiana University
Institutional Review Board (IRB) and should be in ac-
cordance with governmental regulation and policies. All
individuals handling these tissues should be immunized
against Hepatitis A and B and work in a Biosafety level 2
room. Additionally, these individuals should use great
caution and all materials used should be autoclaved be-
fore disposal. Our protocol was approved by the IBC
(Institutional Biosafety Committee) and IRB of Indiana
University School of Medicine, Indianapolis, USA.Preparation of shipping media
Hibernate E medium (Gibco, cat. no. A12476-01) is used
to ship the brain tissue samples from the laboratory/
clinic of origin. The Hibernate E medium is supplemented
with regular 50X B27 (Gibco, cat. no.17504-044), 1 X anti-
biotics cocktail (Mediatech Inc., cat. no. 30-004-CI) and
50 mM Glutamax (Gibco, cat. no. 35050–061). Glutamax
is light sensitive and should be stored appropriately at
room temperature. The shipping media is also used to dis-
sect and process brain tissue samples for the culture in
ambient oxygen.
Brain tissues can be directly shipped from the abortion
clinic (or appropriate centers) to the research laboratory
in cold shipping media. The brain tissues are normally
shipped in 15 mL PET tubes on ice containing at least
Figure 5 Western immunoblotting of the cell lysates from cultures at different DIV shows presence of neuronal, glial and synaptic
proteins (both pre-synaptic and post-synaptic proteins) at different time points of the culture. Band densities of different proteins were
scanned, quantified and normalized with β-actin bands. Levels of neuron specific enolase (NSE), a marker for neurons, and glial fibrillary acidic
protein (GFAP), a glial marker, increase time-dependently in the culture. These may suggest a continual process of neuro- and gliogenesis in the
culture. This finding is in accordance with the presence of NPCs (nestin positive cells) observed at all the time points of the culture. Notably,
presence of synaptic markers (SNAP-25 and PSD-95) even at the later time points indicates non-degenerating nature of the culture.
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sue. The same medium is used for dissecting and pro-
cessing the tissue before plating of the cells. It is
important to prepare the culture within 24 h of brain
tissue collection. Expedited, overnight shipment is rec-
ommended. The shipping media should be made fresh
every 30 days. Any unused brain tissue should be
bleached solution for 15 min. and then disposed in a
biohazard disposal container.Preparation of culture media
Neurobasal medium (Gibco, cat. no.12349-015) is used
for the neuronal culture in the presence of 5% CO2. To
culture neuronal cells, the Neurobasal medium is sup-
plemented by 1X B27, 50 mM Glutamax, 1X antibiotics
cocktail and recombinant human basic fibroblast growth
factor 2 (bFGF) at a concentration of 5 ng/mL of the
media (Gibco, cat. no. PHG0264). It is important recon-
stitute the growth factor (bFGF) properly before use.
Figure 6 Serotonergic and dopaminergic characterization of human mixed brain culture. a Cells at DIV24 were fixed and ICC with 5-HT
antibody revealed presence of serotonergic cells in the culture. The arrows indicate representative cells positive for 5-HT staining. The inset is an
area magnified to better visualize 5-HT positive staining. b Western immunoblotting of the cell lysates indicates presence of GABAergic neurons
(detected by glutamate decarboxylase antibody) in the culture. Number of GABAergic neurons gradually increase as the culture progresses. In
contrast, dopaminergic neurons (detected by tyrosine hydroxylase antibody) are abundant in the initial time points of the culture and gradually
decrease as the culture progresses.
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as a carrier molecule. The reconstituted liquid should be
passed through a 0.2 μm filter, aliquoted and stored
at −20°C. Efforts should be made to avoid repeated
freeze-thaw of the reconstituted bFGF. If the culture
shows frequent signs of contamination, Normocin (Invivo-
Gen, cat. no. ant-nr-1) can be added into the culture
media at a concentration of 2 μL/ mL. The supplements
mentioned above are added to the Neurobasal media and
stored at 4°C for a month. bFGF is mixed to the requiredvolume of media at the time of addition onto the wells.
Some researchers add other growth factors, such as BDNF,
GDNF, NGF or forskolin to induce neuronal differenti-
ation [29]. However, we have observed optimum growth
of the culture in the presence of bFGF alone.
Equipment and reagent setup
Water bath with orbital shaker: The water bath should
be set at 37°C at least 1 h before the tissue dissection.
The orbital shaker speed is to be set at 150 RPM. Plastic
Figure 7 Confocal imaging of Human mixed brain culture containing neurons, glia and neural progenitor cells. At each time point, cells
were fixed using 4% Paraformaldehyde and dual-labeled with FITC-conjugated Neuronal antibody cocktail (Pan-N, 1:1000) and a Cy3-conjugate of
either a glial marker (GFAP, 1:5000) or a neuronal progenitor (Nestin, 1:500). Results at DIV 12, and DIV 32 are shown. Antibodies against Pan-N
and or Pan-N and GFAP were used with appropriate secondary antibodies (donkey-anti mouse; 1:500 or Goat-anti rabbit, 1:2000). Confocal fluorescence
microscopy was performed on an inverted IX81microscope fitted with a FV1000-MPE and laser launch with confocal excitation with three diode lasers
(405, 559 and 635 nm) and an Argon laser (458, 488, 514 nm), controlled by Fluoview v3.0 (Olympus). All imaging was performed with a 60x 1.2 NA
water immersion objective. The scale bar is in the bottom right panel, and is applicable to all images.
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placed at the bottom of the water bath to ensure that
the tube holders uniformly shake at the same speed as
the orbital shaker.
Silicon coating of glass Pasteur pipettes: Glass Pasteur
pipettes’ (preferably 9 inch) should be fire-polished using
a gas burner. One should make sure that the fire-
polished tips are not too narrow (standard tip diameter
should be between 0.75-1.25 mm). For silicon coating,
Sigmacote (Sigma; cat. no.SL-2) is gently aspirated
through the pipette using a dropper bulb aspirator. Once
the Sigmacote reaches the top of the Pasteur pipette, the
dropper bulb is removed from the pipette, allowing the li-
quid to drain down the pipette. In this way, 2–3 Pasteur
pipettes are coated with Sigmacote. Coated Pasteur pi-
pettes were dried for at least 30 min. under hood. Narrowportion of a separate Pasteur pipette was broken to make
a wide-bore opening, fire-polished and siliconized in the
same way as mentioned above. This pipette was used to
transfer brain tissues.
Great caution is required in handling sharp materials.
Sigmacote is highly flammable and should always be
used under hood.
Centrifuge: The centrifuge was setup to the desired
temperature (25-30°C) 2 h prior to the experiment. Ro-
tors and tube holders were properly placed. Each tube
was balanced and properly labeled.
Preparing tissue culture plates
The culture plates were coated with poly D-lysine/PDL
(Sigma, cat. no. P7886). Reconstitution of powdered
PDL was done in sterile water at 100 μg/mL, ran through
Figure 8 Functional response of brain culture. Cells were
cultured on PDL-coated glass coverslips. Approximately 100 regions
of interest (ROI) s were selected indiscriminately. The coverslips are
loaded with Fura-2 dye and placed in standard extracellular solution
(see methods). After depolarization with 70 mM KCl, another wash
with standard extracellular solution is utilized to eliminate dead cells.
The trace shown represents an average (3 experiments) of all cells
that respond to KCl and the second wash. It is important to note
that there were cells that did not respond to KCl which could be
dead cells or non-neuronal cells. Fura emits at two wavelengths –
340 nm and 380 nm [26] and the ratio of these corresponds to the
intracellular calcium. All three points show a calcium response after
induced depolarization, suggesting that these are functionally
active neurons.
Figure 9 An increase in neuronal population over time. Human fetal b
fixed using 4% Paraformaldehyde and dual-labeled with FITC-conjugated N
a glial marker (GFAP, 1:5000) or a neuronal progenitor (Nestin, 1:500). Appro
the boxes refer to percent total of the cells gated for selection that were p
Unlabeled cells. UL-Cells positive for Cy3-conjugated marker for either GFA
Pan-N and GFAP or Pan-N and Nestin. This data suggests that the stem-nes
to emerge.
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(PET) tubes and stored at −20°C for at least 3 months.
The required amounts of PDL were transferred onto every
well of the cell culture plate. Additional file 2: Table S1
shows required volumes of PDL stock (100 μg/mL)
needed to coat different sizes of wells from various plates.
PDL was on the plate overnight in the hood under UV
light. On the day of the culture, the PDL was aspirated off
the wells. The wells were rinsed with sterile water and the
plates were dried under hood for at least 30 min. before
plating the cells. It is important to rinse the wells with
sterile water to completely remove residual PDL hydro-
bromide solution. Residual PDL can leave bromide salt on
the plate, which is toxic to cells.
The dried PDL-coated plates can be stored at 4°C for
3–4 weeks. For plating cells on glass cover slips, auto-
claved cover slips were placed using sterile forceps in
wells with a diameter at least 1.25 times larger than the
diameter of the cover slips. PDL coating was performed
in the same way as mentioned above. Alternative to
PDL, Poly-L-Ornithine, poly L-lysine or collagen can be
used. However, poly L- Lysine is susceptible to degrad-
ation by the enzymatic actions of proteases released
from the cells.
Vacuum adjustment in the sterile hood: It is important
to reduce the suction pressure of the in-line vacuum or
vacuum pump within the sterile hood. This vacuum line
was used to aspirate media from the PET (at the time of
culture preparation) or from the cell culture platesrain (HFB) cells were grown as stated. At each time point, cells were
euronal antibody cocktail (Pan-N, 1:1000) and a Cy3-conjugate of either
priate secondary antibodies were used. The values at the corners of
ositive for the appropriate fluorescent-conjugated antibody. LL –
P or Nestin. LR – Cells labeled with Pan-N. UR – Cells positive for either
s of the culture reduces over time and the neuronal phenotype beings
Figure 10 Transfection of human fetal neuron culture using RNAiMAX transfection agent and APP siRNA demonstrates transfectability
of cells. Cells were transfected at DIV19 in a 24-well cell culture plate using 1.75 μL RNAiMAX (Invitrogen) and 20 nM APP siRNA (Applied Biosystems)
as per manufacturer’s instructions. To improve clarity, we have drawn boxes to separate groups. Cell lysates were prepared 72 h post-transfection and
APP levels (22C11, Millipore; Cat #MAB348) assayed by Western blot. APP levels were reduced by over 50% following transfection of APP siRNA. *p < 0.05
by Student’s t-test.
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It is possible that the cell pellet/plated cells can be
accidentally lost while aspirating the media if excessive
vacuum force is used.Procedure
The overview of these steps is outlined in Figure 1.Pre-culture preparation
The laminar cell culture hood surface was wiped with
70% ethanol and the germicidal UV light was turned on
in the laminar flow hood. The autoclaved dissecting
tools, sterile water, pipettes, pipettes tips, 100 mm cell
culture plate were placed inside the cell culture hood

















10 103 118with ice was made available just before the dissection.
The culture media, sterile horse serum (Atlanta biologi-
cals, cat no.S12150H) and trypsin-EDTA were pre-
warmed at 37°C water bath. The tube containing the
brain tissue in shipping media was removed from the
shipping package and kept refrigerated.
It is important to maintain a record of the received
brain tissues with detailed information (such as tissue
code number, gender, gestational age, any birth defect,
time of abortion).Dissection/preparation of tissue
A 100 mm tissue culture plate containing 5 mL of ship-
ping media was placed in the ice bucket. The brain tissue
was transferred to the culture plate containing shipping
media using the wide-bore siliconized Pasteur pipette.
Any visible blood vessels and blood contaminated tissue
were gently removed from the brain tissue mass. Effort
should be made to have 7–15 gm. of cleaned tissue in
order to yield sufficient number of cells.
The cleaned tissue was carefully chopped with the
scalpel blade to create sections of approximately 0.5 mm
thickness. It is important to note that the human sam-
ples are biohazards and personal protective equipment
must be worn during dissection/preparation of the
samples. Bleach solution was added to the plate con-
taining removed tissue debris and tissue then discarded
into the biohazard disposal container.Enzymatic digestion of the brain tissue
The brain tissue mass was transferred into a 50 mL PET
tube containing 10 mL of trypsin-EDTA and the tube
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The tube was oscillated the water bath at 150 RPM for
10–15 min.
The timing of enzymatic digestion is crucial for viabil-
ity and yield of neuronal cells in the culture. We gener-
ally performed 15 min. digestion for brains that are
obtained from the fetuses with gestational ages more
than 105 days. Brains from lesser gestational age fetuses
(typically less than 100 days) may require a 12 min. di-
gestion. After the digestion, the tubes containing the
brain tissue were wiped with 70% ethanol, brought back
to the cell culture hood and 1 mL of sterile horse serum
was immediately added to the trypsin-EDTA solution to
stop the enzymatic reaction.
Isolation of cells from the tissue
The cell mass was transferred by the wide-bore glass
Pasteur pipette from trypsin-EDTA to 15 mL PET tube,
containing 5 mL of DM. It is convenient to equally dis-
tribute tissue into two separate 15 mL PET tubes, each
containing 5 mL of DM. Dividing the tissue mass in this
manner eliminates the need for balancing during centri-
fugation. Fire-polished siliconized Pasteur pipette was
used to triturate the tissue with moderate force in the
shipping media. Triturating 10–12 times is generally suf-
ficient to obtain a fairly homogenous suspension of cells.
Vigorous or prolonged trituration can damage the cells
resulting in lower/no cell yield. Some undigested mucin-
ous brain tissue remnants are often present after tritur-
ation. Those to be removed from the tube and discarded
into the appropriate biohazard waste container.
The tubes containing the brain homogenate were
placed into the swinging tube holders of the centrifuge
and centrifuged at 400 g at room temperature (22-27°C)
for 5–8 minutes. Centrifugation will spin down all viable
cells to the bottom of the tubes. After centrifugation, the
tubes were gently removed from the centrifuge, wiped
with 70% ethanol and placed in the sterile hood. The
supernatant media was discarded using an untreated
Pasteur pipette attached to the in-line vacuum.
Five (5) mL of fresh shipping media was poured into
the tubes. The trituration step (as mentioned on above)
was repeated once more, followed by further centrifuga-
tion at 400 g at room temperature for 5–8 minutes.
After centrifugation, the supernatant media was gently
aspirated out and add 3 mL of fresh shipping media was
added into the tubes. The homogenate was mixed in the
media by gently tapping the tubes or by slow pipetting
with a P1000 micropipette. The cell suspensions from
two different tubes were transferred into a single PET
tube. The cell suspension (20 μL) was mixed with 180 μL
of sterile DPBS (Cellgro, cat. no. 20-0131-CV; 1:100 dilu-
tions). 10 μL of the diluted cell suspension was transferred
into a sterile microfuge tube and 10 μL of trypan blue wasand gently mixed and cell counting was carried out in a
hemocytometer. Table 1 shows the average yield of cell
number from Human fetal brain tissue samples that were
obtained from aborted fetus of gestational age between
90–110 days. Aborted fetal brain tissues can be obtained
from local abortion clinics or national distribution labs. In
this study, we procured of cells obtained from brain tissue
specimens. Cell counting can be performed in any auto-
matic or semiautomatic cell counter following manufac-
turer’s instruction.
Cell plating
Cells (brain homogenate) were plated in PDL-coated
plates (15000–25000 cells/cm [2]) using the defined cul-
ture medium (Neurobasal with supplements and antibi-
otics) with a P200 micropipette. Suggested volumes for
plating are included in Additional file 1: Figure S1. Cell
culture plates were swirled gently for uniform seeding of
cells in the wells
Efforts should be made not to expose cells to ambient
CO2 for more than 5 min. to minimize change in pH of
the culture medium. It should be kept in mind that
many cells in the fetal brain are NPCs, i.e. in presence of
bFGF, these cells give rise to neurons and glia (Figures 2, 3
and 4). Plating too many cells can eventually result in ex-
cess cell density on the plate. Within 16–24 h of cell plat-
ing, the existing media was gently aspirated out using the
in-line vacuum and replenish with freshly prepared de-
fined culture medium. This step is important to remove
unwanted cellular debris. Accumulation of cellular debris
in the wells can retard cellular growth and also promote
microbial contaminations. Reduced force of the in-line
vacuum is necessary before aspirating the media.
Culture propagation
(i) 50% of the media was removed from the wells every
4th day and replaced by the same volume of media con-
taining 2X growth factors until the termination of the cul-
ture. Representative morphology of cells at different time
points is shown (Figure 2). Experiments on these cultures
can be performed from 20–24 DIV onwards or earlier or
later depending on the specific need of the experiments.
(ii) We have observed the presence of abundant neurons
and neuronal protein markers even at DIV 40 of the culture.
Absence of bFGF at early time points (up to DIV10-14) of
the culture resulted in low cell yield. Withdrawal of bFGF at
a later time point can make neurons degenerate gradually
over time and can be used for specific drug studies [30].
Western immunoblotting
Western immunoblotting to detect proteins of interest
was performed as previously described [31]. Briefly,
culture cells were lysed by adding Mammalian Protein
Extraction Reagent (M-PER; ThermoScientific; cat. no.
Table 2 List of different primary and secondary antibodies used to characterize the culture
Primary antibody Dilutions Company Cat.no. Secondary antibody Dilutions Company Cat.no.





Glial Fibrillary Acidic protein
(GFAP) (WB)
1:20,000 Sigma G9269 HRP-conj. Goat anti Rabbit 1:7,500 Thermo Scientific 31460
Glial Fibrillary Acidic protein
(GFAP) (ICC)
1:10,000 Sigma G9269 Cy3-conj. Donkey anti Rabbit 1:500 Jackson Immuno
Research
711-165-152
Nestin (ICC) 1:1000 Sigma N5413 Cy3-conj. Donkey anti Rabbit 1:500 Jackson Immuno
Research
711-165-152
Neuron-specific Enolase (NSE) (WB) 1:3000 Abcam ab16873 HRP-conj. Goat anti Rabbit 1:7,500 Thermo Scientific 31460
Synaptosomal-associated Protein
of 25 kDa (SNAP25) (WB)
1:5000 Millipore MAB331 HRP-conj. Goat anti Mouse 1:3000 Rockland 610-1319
Post Synaptic Density Protein
of 95 kDa (PSD-95) (WB)
1:3000 NeuroMab 75-028 HRP-conj. Goat anti Mouse 1:3000 Rockland 610-1319
β actin (WB) 1:100,000 Sigma A5441 HRP-conj. Goat anti Mouse 1:3000 Rockland 610-1319





1:1000 Millipore AB1511 HRP-conj. Goat anti Rabbit 1:7,500 Thermo Scientific 31460
Tyrosine Hyroxylase (WB) 1:2000 Millipore MAB318 HRP-conj. Goat anti Mouse 1:3000 Rockland 610-1319
Amyloid Precursor Protein
(APP) (22C11 clone)
1:3000 Millipore MAB348 HRP-conj. Goat anti Mouse 1:3000 Rockland 610-1319
α-tubulin 1:100,000 Sigma T9026 HRP-conj. Goat anti Mouse 1:3000 Rockland 610-1319
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directly to wells followed by shaking the plates on or-
bital shaker. Laemmli sample buffer was added to the
cell lysates and boiled for 5 min. A list of antibodies
used is provided in Table 2.
Immunocytochemistry (ICC)
Cellular phenotypes were assessed by immunocytochem-
ical (ICC), flow cytometry and confocal microscopy using
neuronal antibody markers. For all these experiments,
cells were fixed using paraformaldehyde (4%) and perme-
abilized by 0.13% triton X-100, followed by blocking with
10% horse serum per standard ICC protocols. Fixed cells
were incubated overnight with neuron and glial-specific
primary antibodies. Appropriate secondary antibodies and
fluorophores were utilized to obtain fluorescence images
as described before [4]. Figure 3 shows phenotypic charac-
ter of the culture and also indicates that maturation of
neurons (i.e. neurons and glial markers do not overlap) at
DIV 24 onwards of the culture. Figure 6 shows presence
of different types (for example, glutamatergic) of neurons
at selected time points of the culture.
Transfection
Transfection of the cells was carried out using standard
transfection reagent such as lipofectamine (for DNA
constructs) and RNAiMAX (for small RNA). Transfec-
tion complexes were made using 50 μl/well Opti-MEM
1 (Gibco, Cat # 11058–021). Mock-transfected cellscontained the Opti-Mem and 1. 75 μl/well RNAiMax,
but no RNA. 20 nM APP siRNA was used to confirm
transfectability of cells. The cells were transfected on
DIV 19 at 37°C for 48 hours. After a PBS wash, 125 μL
of M-per buffer (containing protease inhibitor) was used
to lyse the cells (Figure 10).
Calcium imaging study
Calcium imaging was performed using Fura2-AM. Cells
were incubated with Fura-2 AM for 1 h. After 3x PBS
washes, the coverslips were placed in ‘standard extracellu-
lar solution buffer containing NaCl 130 mM, KCl 2 mM,
MgCl2 1 mM, CaCl2 5 mM, glucose 5.5 mM, Hepes
10 mM, pH 7.2. 70 mM KCl was used to depolarize the
cells. The baseline for all traces was transposed to
allow comparison of peaks. T.I.L.L. Photonics (München,
Germany) imaging system was used to obtain the data.
Additional files
Additional file 1: Figure S1. The merged images from Figure 7 were
auto-enhanced using ImageJ software. The top panel contains images
from three different time points that are stained for a neuronal (Pan-N)
and glial marker (GFAP). The bottom panel contains images from the
same time points that are stained for neuronal (Pan-N) and neuronal
progenitor (Nestin) marker. The auto-enhancement facilitates better
visualization of the staining. However, it is not meant to be interpreted as
indicative of staining across time points – as each image has its own
auto-enhanced settings.
Additional file 2: Table S1. Amount of poly-D-lysine required to coat
different size of cell culture plates.
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